FindTrial
Sign In

Histomorphometric and immunohistochemical evaluation of beta-tricalcium phosphate of different particles dimensions in maxillary sinus floor elevation: a randomized clinical study

Prospective, randomized clinical study for bone repair after grafting on human maxillary sinuses

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-63c3gn
Enrollment
Unknown
Registered
2020-06-03
Start date
2019-01-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomatognathic diseases

Interventions

Group 1: composed of 6 patients and 6 maxillary sinuses in total, whose floor was elevated and filled with autogenous bone collected from the mandibular ramus or chin. Group 2: composed of 6 patients
Biological/vaccine
Procedure/surgery
E04.545.668

Sponsors

Faculdade de Odontologia de Araçatuba
Lead Sponsor
Faculdade de Odontologia de Araçatuba
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Atrophic posterior maxillary region and residual bone height less than 5 mm requiring bone augmentation rehabilition with dental implants.

Exclusion criteria

Exclusion criteria: smokers, patients with uncontrolled systematic disease, maxillary sinus diseases, and patients with an inadequate amount of bone in the mandible symphysis where the autogenous bone graft was harvested.

Design outcomes

Primary

MeasureTime frame
It is expected to find an increase in the alveolar bone height, assessed by means of computed tomography and histomorphometry, from the observation of neoformed bone tissue on the remaining border.—

Secondary

MeasureTime frame
Secondary outcomes are not expected—

Countries

Brazil

Contacts

Public ContactBruno Mendes

Faculdade de Odontologia de Araçatuba

brunocoelho.mnds@gmail.com65981499916

Outcome results

None listed

Source: REBEC (via WHO ICTRP)